CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.93B, above the global median of $1.15B
- FinancialsAltman Z-Score 7.91: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.87%
Annual Rate
CNY 0.12Paid unknown
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.99BCNY1.93B · vs all stocks (USD)
Trailing P/E
48.04xRevenue (TTM)
1.75BCNY260.24M · vs all stocks (USD)
Profit Margin
15.20%Beta
0.1050xvs all stocks
52-Week Change
-44.66%vs all stocks
Market Capitalization
12.99BCNY1.93B · vs all stocks (USD)
Enterprise Value
10.09BCNY1.50B · vs all stocks (USD)
Trailing P/E
48.04xPrice to Sales (TTM)
7.12xPrice to Book (MRQ)
3.78xEnterprise to Revenue
5.76xEnterprise to EBITDA
25.86xGross Margin
84.10%Profit Margin
15.20%Operating Margin
21.73%Return on Assets (TTM)
3.62%Return on Equity (TTM)
8.07%Revenue (TTM)
1.75BCNY260.24M · vs all stocks (USD)
Revenue per Share (TTM)
1.84CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-5.30%Gross Profit (TTM)
1.41BCNY209.61M · vs all stocks (USD)
EBITDA (TTM)
291.09MCNY43.23M · vs all stocks (USD)
Net Income (TTM)
266.34MCNY39.56M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
54.30%Operating Cash Flow (TTM)
652.66MCNY96.93M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
225.50MCNY33.49M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1200CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.87%vs all stocks
Minority Interest (Equity)
58.71MCNYFY2025 · Dec 31, 2025Revenue
1.78BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
351.87MCNYFY2025 · Dec 31, 2025Gross Profit
1.43BCNYFY2025 · Dec 31, 2025Operating Income
236.77MCNY35.16M · vs all stocks (USD)
Pre-tax Income
253.09MCNYFY2025 · Dec 31, 2025Income Tax Expense
39.38MCNYFY2025 · Dec 31, 2025Net Income
213.72MCNYFY2025 · Dec 31, 2025EBIT
253.99MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
369.78MCNYFY2025 · Dec 31, 2025Research & Development
158.61MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
962.82MCNYFY2025 · Dec 31, 2025Other Operating Expenses
27.62MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
895.88KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
946.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
946.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
213.72MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
22.89MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
290.83MCNYFY2025 · Dec 31, 2025Free Cash Flow
147.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.41BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
213.72MCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.31MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
967.81KCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
69.84MCNYFY2025 · Dec 31, 2025Capital Expenditures
-143.41MCNYFY2025 · Dec 31, 2025Net Acquisitions
519.95KCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.78BCNYFY2025 · Dec 31, 2025Sale of Investments
4.49BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-440.67MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
47.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-82.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-111.47MCNYFY2025 · Dec 31, 2025Other Financing Charges
26.05MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-120.43MCNYFY2025 · Dec 31, 2025Shares Outstanding
928.16MSharesUpdated Aug 20, 2026Float Shares
264.66MSharesUpdated Aug 20, 2026% Held by Insiders
71.53%vs all stocks
% Held by Institutions
7.36%vs all stocks
Total Cash (MRQ)
2.48BCNY368.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.67CNYUpdated Aug 20, 2026Total Debt (MRQ)
6.31MCNY937.72K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0019xCurrent Ratio (MRQ)
2.73xBook Value per Share (MRQ)
3.56CNYUpdated Aug 20, 2026Total Assets
4.52BCNY670.88M · vs all stocks (USD)
Total Current Assets
2.99BCNYFY2025 · Dec 31, 2025Total Liabilities
1.24BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.53BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
76.14MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.17BCNYFY2025 · Dec 31, 2025Cash
1.42BCNYFY2025 · Dec 31, 2025Cash Equivalents
2.08MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.42BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.06BCNYFY2025 · Dec 31, 2025Accounts Receivable
205.48MCNYFY2025 · Dec 31, 2025Inventory
124.55MCNYFY2025 · Dec 31, 2025Accounts Payable
121.07MCNYFY2025 · Dec 31, 2025Short-term Debt
29.79MCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.58MCNYFY2025 · Dec 31, 2025Long-term Debt
4.04MCNYFY2025 · Dec 31, 2025Common Stock (Book)
928.16MCNYFY2025 · Dec 31, 2025Retained Earnings
1.87BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.27BCNY486.27M · vs all stocks (USD)
52-Week Low
12.06CNYUpdated Aug 20, 202652-Week High
25.75CNYUpdated Aug 20, 202652-Week Change
-44.66%vs all stocks
Beta
0.1050xvs all stocks
50-Day MA
13.52CNYUpdated Aug 20, 2026200-Day MA
15.62CNYUpdated Aug 20, 2026Avg 10-Day Volume
10.19MSharesUpdated Aug 20, 2026Avg 30-Day Volume
12.43MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.2800CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.91: safe zoneNotable
Altman Z-Score: 7.91
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.93B, above the global median of $1.15BNotable
Market cap (USD): 1,929,905,254.627Global Median: 1,146,734,693.424
Levered free cash flow is $33.49M, above the global median of $16.24MNotable
Levered free cash flow (USD): 33,491,545.158Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Damora Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Galapagos NV
Tier 1ProductionApproval-Gated PipelineRuleRisk
Fagron NV
Tier 1ProductionApproval-Gated PipelineFlowRule
Tyra Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
ChemoMetec A/S
Tier 1ProductionApproval-Gated PipelineRule
Harmony Biosciences Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Urogen Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ocular Therapeutix Inc.
Tier 1ProductionApproval-Gated PipelineRule
Amylyx Pharmaceuticals, Inc. Common Stock
Tier 1ProductionApproval-Gated PipelineRule
GH Research plc
Tier 1ProductionApproval-Gated PipelineRule